Latest Side effects Podcast Episodes
#30 Preventing and reporting medication errors – Rabat CC & UMC
Drug Safety Matters - May 15, 2024 11:00 - 33 minutesLook-alike medicines, unclear communication and distractions during administration – medication errors may occur for many different reasons. They all have in common that they are unintended mistakes in the drug treatment process that may or may not lead to patient harm. In this episode Ghita Ben...
#29 When medicines change our behaviour – Michele Fusaroli
Drug Safety Matters - April 23, 2024 09:00 - 30 minutesMedicines can affect our personality in positive ways, but they may also lead to destructive behaviours that can damage our relationships, finances, and overall quality of life. Michele Fusaroli from the University of Bologna explains how to diagnose and treat drug-induced impulse control disord...
#28 Catching black swans – François Montastruc
Drug Safety Matters - February 29, 2024 08:00 - 27 minutesSerious and unexpected adverse drug reactions – the ‘black swans’ of pharmacovigilance – can place enormous strain on safety monitoring systems. Drawing examples from the COVID-19 pandemic, François Montastruc from Toulouse University Hospital explains how we can get better at dealing with the u...
#27 When drugs damage the liver – Rita Baião
Drug Safety Matters - February 01, 2024 09:00 - 28 minutesThe liver is the primary site for drug metabolism in the body, but it can be severely damaged by medicines or their toxic compounds. Rita Baião from the North Lisbon University Hospital Center reviews what pharmacovigilance professionals should know about drug-induced liver injury (DILI). Tune ...
#26 What's trending in pharmacovigilance? – Angela Caro
Drug Safety Matters - December 20, 2023 08:00 - 28 minutesWhat did the drug safety community achieve in 2023 and how will the field develop in 2024? As the year comes to a close, we asked Angela Caro, president of the International Society of Pharmacovigilance (ISoP), to walk us through current and future trends in pharmacovigilance. Tune in to find o...
#25 A week in the name of medicines safety – part 2
Drug Safety Matters - November 13, 2023 10:00 - 33 minutesTo mark #MedSafetyWeek, which took place from 6–12 November, we’re releasing a special two-part episode on pharmacovigilance communication campaigns. In this second part, we hear from three #MedSafetyWeek veterans – Anne-Cécile Vuillemin from the Ministry of Health in Luxembourg, Ban Al-Shimran ...
#24 A week in the name of medicines safety – part 1
Drug Safety Matters - November 02, 2023 13:00 - 27 minutesTo mark #MedSafetyWeek, which takes place from 6–12 November, we’re releasing a special two-part episode on pharmacovigilance communication campaigns. In this first part, we speak to Mitul Jadeja from the Medicines and Healthcare products Regulatory Agency in the UK about under-reporting and how...
Uppsala Reports Long Reads – The colour of signals
Drug Safety Matters - September 29, 2023 14:00 - 33 minutesHerbal remedies have been used for thousands of years to treat what ails us. Yet why do we still know so little about their potential side effects compared to modern medicines? This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance ...
Uppsala Reports Long Reads – Empowering patients as partners
Drug Safety Matters - September 05, 2023 12:00 - 42 minutesA patient's perspective can ensure safe medical care and lead to new insights that traditional research may overlook. But how do we best harness that perspective to improve patient outcomes? This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s phar...
#23 Assessing safety in clinical trials – Marianne Lunzer & Sanja Prpić
Drug Safety Matters - June 27, 2023 14:00 - 31 minutesMedicines safety monitoring is a continuous process that begins with pre-marketing clinical trials and continues with post-marketing studies to fill any gaps in knowledge. With Marianne Lunzer from AGES and Sanja Prpić from HALMED, we review the pros and cons of various study types and the impor...
#22 Reforming pharmacovigilance education – Michael Reumerman
Drug Safety Matters - May 08, 2023 12:00 - 32 minutesHealthcare professionals are key players in medicines safety but they often lack the time or knowledge to report adverse drug reactions. To change that, we need to urgently rethink how we teach pharmacovigilance, argues Michael Reumerman from Amsterdam University Medical Centers. Tune in to fin...
#21 Unlocking the power of real-world data – Patrick Ryan
Drug Safety Matters - March 30, 2023 09:00 - 33 minutesThe vast amount of real-world data collected during routine clinical care is a treasure trove of safety information – but there are challenges to overcome before this rich source of evidence can be applied to pharmacovigilance. Patrick Ryan from Johnson & Johnson discusses how to harness real-wo...
#20 The evidence for signals – Daniele Sartori
Drug Safety Matters - February 23, 2023 08:00 - 45 minutesSpontaneous reports of adverse drug reactions are a common source of evidence in pharmacovigilance, but as the science evolves, so do the types of data used to find and assess signals. Uppsala Monitoring Centre’s Daniele Sartori reviews how signal detection practices have changed over time. Tun...
Uppsala Reports Long Reads – Unmasking data in the COVID-19 vaccine era
Drug Safety Matters - January 26, 2023 12:00 - 21 minutesMost pharmacovigilance professionals will have heard of masking – a statistical issue where reports for one drug hide signals for other drugs. But the problem gained fresh attention when record amounts of reports began piling up for the COVID-19 vaccines. How should we be unmasking data in the C...
#19 Lessons in pandemic pharmacovigilance – Elena Rocca
Drug Safety Matters - December 15, 2022 08:00 - 33 minutesThe COVID-19 pandemic forced pharmacovigilance experts to revisit their processes to deal with unprecedented volumes of data and catch unexpected safety issues. Elena Rocca from Oslo Metropolitan University reviews the challenges of a global healthcare emergency – and what it can teach us about ...
#18 The IDMP standards explained – Malin Fladvad & Olle Lagerlund
Drug Safety Matters - September 29, 2022 08:00 - 23 minutesThe Identification of Medicinal Products (IDMP) standards promise to harmonise how pharmaceutical products and substances are described around the world. But how will that benefit patients and who will make sure the standards are properly implemented? Uppsala Monitoring Centre’s Malin Fladvad an...
#17 Why we need vaccine surveillance systems – Madhava Balakrishnan
Drug Safety Matters - August 24, 2022 12:00 - 27 minutesPublic trust in vaccines hinges on their safety – but to make sure vaccines are safe, we must have systems in place to detect and manage any side effects. Dr Madhava Ram Balakrishnan, medical officer for vaccine safety at the World Health Organization, discusses how to build an effective vaccine...
#16 How drug safety can help fight resistant bugs – Jean Marie Vianney Habarugira & Albert Figueras
Drug Safety Matters - June 30, 2022 07:00 - 33 minutesManaging antimicrobial resistance (AMR) will require innovative solutions from many different disciplines. Could pharmacovigilance be one of them? Jean Marie Vianney Habarugira and Albert Figueras, who have been investigating how drug safety tools could help track AMR, think it’s time the two co...
#15 Safety of HIV medications – Henry Zakumumpa
Drug Safety Matters - April 29, 2022 13:00 - 33 minutesWith the right care, people infected with HIV can lead long and healthy lives. But as with any life-long medical treatment, it is important to acknowledge and manage any side effects. Henry Zakumumpa from Makerere University School of Public Health tells us about the potential harms of new HIV t...
#14 Advancing pharmacovigilance in Africa – Eleni Aklillu & Abbie Barry
Drug Safety Matters - March 24, 2022 08:00 - 37 minutesAccess to medical products has increased considerably in Africa in recent years, but safety monitoring systems haven’t exactly kept pace and many African countries still struggle to address safety issues. We sat down with Eleni Aklillu and Abbie Barry of the PROFORMA project to learn about their...
#13 How to talk about risks – Alexandra Freeman
Drug Safety Matters - February 24, 2022 08:00 - 38 minutesPeople’s perception of risk can vary greatly from person to person, making it challenging for healthcare professionals to communicate benefits and harms of medicines in a balanced fashion. Alexandra Freeman from the Winton Centre for Risk and Evidence Communication discusses how to give patients...
How to utilize the web to benefit your life
The Smoke A Fatty With Paddy Show Podcast - February 07, 2022 08:00 - 5 minutes| | RUMBLE - https://rumble.com/user/CRYPTOWARLIVE | | Twitter - https://twitter.com/PaddyDrapes | | www.smokeafattywithpaddy.news | | www.smokeafattywithpaddy.com | | www.cryptowar.LIVE | | Telegram - https://t.me/cryptowarlive | | itrustCapital 401k/IRA | | ABOUT ME - https://www.smo...
Subconscious Mind Programing 101
The Smoke A Fatty With Paddy Show Podcast - February 06, 2022 07:00 - 4 minutesYou are what you want to be. | | RUMBLE - https://rumble.com/user/CRYPTOWARLIVE | | Twitter - https://twitter.com/PaddyDrapes | | www.smokeafattywithpaddy.news | | www.smokeafattywithpaddy.com | | www.cryptowar.LIVE | | Telegram - https://t.me/cryptowarlive | | itrustCapital 401k/IRA...
The Value in everyone and everything. Level up your conscience
The Smoke A Fatty With Paddy Show Podcast - February 05, 2022 05:00 - 3 minutes- teams work faster (and harder) on the less enjoyable tasks to stay on schedule. - You’ll have to give yourself more time to complete the less enjoyable task to put the required amount of effort and work in to do the task well, leading to a delay in the overall project with negative perception....
Hardships are assets
The Smoke A Fatty With Paddy Show Podcast - February 04, 2022 05:00 - 3 minutes| RUMBLE - https://rumble.com/user/CRYPTOWARLIVE | Twitter - https://twitter.com/PaddyDrapes | www.smokeafattywithpaddy.news | www.smokeafattywithpaddy.com | www.cryptowar.LIVE | Telegram - https://t.me/cryptowarlive | itrustCapital 401k/IRA | ABOUT ME - https://www.smokeafattywithpaddy...
2.2.2022 sending positive vibes
The Smoke A Fatty With Paddy Show Podcast - February 02, 2022 15:00 - 5 minutesYou never know who depends on you and you never know how much you can change somebody’s day by acknowledging something that they do well or above the norm. Words carry vibrations, facial expressions carry vibrations, we are essentially vibrations in themselves. Go try to make 10 people smile tod...
2.1.2022_______Mastering Your Destiny
The Smoke A Fatty With Paddy Show Podcast - February 02, 2022 07:00 - 12 minutes| RUMBLE - https://rumble.com/user/CRYPTOWARLIVE | Twitter - https://twitter.com/PaddyDrapes | www.smokeafattywithpaddy.news | www.smokeafattywithpaddy.com | www.cryptowar.LIVE | Telegram - https://t.me/cryptowarlive | itrustCapital 401k/IRA | ABOUT ME - https://www.smokeafattywithpaddy...
Uppsala Reports Long Reads – Safety issues faced by refugee communities
Drug Safety Matters - January 27, 2022 10:00 - 25 minutesThe loss of vital health records is a universal problem for refugees. When their medical information goes missing, patients are less likely to receive the care they need and more likely to be prescribed the wrong treatments. Thankfully, the International Society of Pharmacovigilance Egypt Chapte...
CRYPTO WAR LIVE- YOUTUBE DELETED MY CHANNEL- 1/9/2022 -
The Smoke A Fatty With Paddy Show Podcast - January 09, 2022 06:00 - 2 hoursThis video is here to give you a detailed comparison between HBAR (Hedera Hashgraph) and XRP (Ripple Labs), *Disclaimer* The information contained here is created for informational purposes only, nothing in the video should be considered financial legal or tax advice. The content of this video...
#12 Improving signal detection with vigiGroup – Jim Barrett & Joe Mitchell
Drug Safety Matters - December 16, 2021 15:00 - 23 minutesStatistical tools can not only cut through the noise in large pharmacovigilance databases. They can also help identify more clinically meaningful patterns in the data. Uppsala Monitoring Centre’s Jim Barrett and Joe Mitchell explain how vigiGroup, a novel clustering algorithm, can bring value to...
Related Side effects Topics